课题基金 / 基金详情

Mechanisms Underlying Heterotopic Ossification

Mechanisms Underlying Heterotopic Ossification
异位骨化的潜在机制
批准号:
9033067
负责人:
JOHN A KESSLER
金额:
$39.23万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2020-02-29

项目摘要

项目成果

JOHN A KESSLER的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):异位骨化的潜在机制异位骨化(HO)是正常骨骼系统外的真正骨形成。HO的确切机制尚不清楚,尽管许多信号通路和细胞成分,局部和全身,已被牵连。我们以前的工作表明,神经炎性因子,P物质(SP),沿着肥大细胞和巨噬细胞的失调,导致骨形态发生蛋白(BMP)信号升高,触发病理过程。表达Glast和Tie 2的间充质干/祖细胞(MSCs)响应诱导信号并通过软骨内骨化形成异位骨。我们的中心假设是,与正常的骨骼发生不同,HO的过程是一种损伤/炎症诱导的异常局部形态发生现象。具体而言,多种疾病特异性贡献因子,包括细胞和细胞外分子元件,彼此协调以形成独特的分层微环境,类似于内源性干细胞小生境,以诱导和繁殖HO。在小生境中,从局部组织募集的MSC是HO的起源细胞,并且特定的局部支持性细胞(例如局部神经元、肥大细胞)和分子(例如SP)组分对于调节这些MSC的定型自我更新、增殖、成软骨和成骨分化至关重要。因此,治疗方法的发展必须考虑局部神经支配和肥大细胞以及HO起源细胞的局部来源的作用。这需要一个跨学科的方法来研究利基作为一个最小的功能单位,本建议的目标。了解HO起源细胞的特征对于精确的治疗靶向是必要的, 预防或限制疾病。拟议研究的第一部分将检查直接参与HO的小生境居住细胞。第二部分将研究小生境支持细胞和启动和传播HO的关键分子组分。一个主要的焦点将是检查通过抑制在HO生态位中起核心作用的因子(如SP)来预防或限制HO的治疗效果。因此,总体目标是开发一种治疗这种目前没有有效治疗的衰弱性疾病的疗法。
英文摘要
 DESCRIPTION (provided by applicant): Mechanisms Underlying Heterotopic Ossification Heterotopic ossification (HO) is bona fide bone formation outside of the normal skeletal system. The precise mechanisms underlying HO are unknown, although numerous signaling pathways and cellular components, local and systemic, have been implicated. Our previous work demonstrated that dysregulation of the neuroinflammatory factor, substance P (SP), along with mast cells and macrophages, leads to elevated bone morphogenetic protein (BMP) signaling that triggers the pathological process. Glast and Tie2 expressing mesenchymal stem/progenitor cells (MSCs) respond to the inductive signals and form ectopic bone through endochondral ossification. Our central hypothesis is that unlike normal skeletogenesis, the process of HO is an injury/inflammation induced, abnormal local morphogenic phenomenon. Specifically, multiple disease specific contributing factors, including both cellular and extracellular molecular elements, co-ordinate with each other to form a unique hierarchical microenvironment, similar to endogenous stem cells niches, to induce and propagate HO. In the niche, MSCs recruited from local tissues are the cells of origin of HO, and specific local supportive cellular (e.g. local neres, mast cells) and molecular (e.g. SP) components are crucial to regulate the stereotyped self-renewal, proliferation, chondrogenic and osteogenic differentiation of these MSCs. Thus development of therapeutic approaches must consider the role of the local innervation and mast cells as well as local sources of cells of origin of HO. This requires an interdisciplinary approac to study the niche as a minimum functional unit, the goal of this proposal. Understanding the characteristics of the cells of origin of HO will be necessary for precise therapeutic targeting to prevent or limit the disorder. The first part of the proposed studies will examine the niche dwelling cells that directly participate in HO. The second part will study the niche supportive cells and key molecular components that initiate and propagate HO. A major focus will be to examine the therapeutic effectiveness in preventing or limiting HO by inhibiting factors, such as SP, that play a central role in the HO niche. Thus the overall goal is to develop a therapy for thi debilitating disorder for which there currently is no effective treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Hippocampal Neurogenesis and Behavior by Noggin
Immune-modifying nanoparticles for the treatment of traumatic brain injury
Immune-modifying nanoparticles for the treatment of traumatic brain injury
Immune-modifying nanoparticles for the treatment of traumatic brain injury
海外基金